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Background: Early discontinuation of clopidogrel after drug-eluting stent (DES) is associated with an increased risk of early adverse cardiovascular 
events. Prevalence and predictors of premature discontinuation are poorly known.
Methods: We collected demographic and baseline data for patients who underwent DES implantation and followed up with them at 1 year. We 
divided the population into 2 groups whether they discontinued clopidogrel or not, and compared them.
Results: Among 5040 patients discharged on dual antiplatelet therapy (DAPT), 898 (17.8%) stopped clopidogrel prematurely. Those who stopped 
were older (66.3±11.96 vs. 64.1±11.5, p<0.001), weighed less (85.9±19.5 vs. 88.5±20.2, p<0.001), had chronic renal insufficiency (CRI) (14.3% 
vs. 9.9%, p<0.001), and were on Coumadin (10.4% vs. 5.5%, p<0.001). After adjustment, CRI and saphenous vein graft (SVG) percutaneous 
revascularization were associated with higher discontinuation (OR: 1.38, [1.041-1.829], p=0.0252) and (OR: 0.553, [0.348-0.879], p=0.0123), 
respectively. Uninsured patients and the Medicare population discontinued more often than those with private insurances (OR: 1.976, [0.944-
4.137], p<0.001) and (OR: 1.531, [1.256-1.867], p=0.07).
Conclusions: Our results show that in a North American population, CRI, percutaneous revascularization of a SVG and non private insurance are 
the strongest correlates to early discontinuation of DAPT following DES implantation.
Multivariate analysis: variables associated with Clopidogrel discontinuation
OR 95% CI P value
Medicaid vs. Private 0.923 0.0505-1.688 0.7952
Medicare vs. Private 1.531 1.256-1.867 <0.001
Uninsured vs. Private 1.976 0.944-4.137 0.0707
CRI 1.380 1.041-1.829 0.0252
African American 1.08 0.858-1.359 0.5133
Male 0.973 0.792-1.195 0.7907
SVG 0.553 0.348-0.879 0.0123
